Target Healthcare REIT (LON:THRL – Get Free Report)’s share price hit a new 52-week high during trading on Thursday. The company traded as high as GBX 117 and last traded at GBX 113, with a volume of 94144 shares changing hands. The stock had previously closed at GBX 113.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group restated a “hold” rating and set a GBX 101 price objective on shares of Target Healthcare REIT in a report on Wednesday, August 5th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of GBX 101.
Get Our Latest Stock Analysis on THRL
Target Healthcare REIT Price Performance
Target Healthcare REIT (LON:THRL – Get Free Report) last posted its earnings results on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share for the quarter. Target Healthcare REIT had a net margin of 114.60% and a return on equity of 11.03%. Equities research analysts predict that Target Healthcare REIT will post 6.2219101 earnings per share for the current fiscal year.
About Target Healthcare REIT
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Further Reading
- Five stocks we like better than Target Healthcare REIT
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
